Sabin Vaccine Institute Announces the Election of Four New Members to Board of TrusteesBy Sabin Vaccine Institute, PRNE
Wednesday, July 13, 2011
WASHINGTON, July 14, 2011 -
The Sabin Vaccine Institute (Sabin) is pleased to announce the
election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro,
and Alisa Swidler to the organization’s Board of Trustees.
“We are honored to have such distinguished individuals join the
Sabin Board,” said Morton Hyman, Chairman of the Board of Trustees.
“We appreciate their trust and confidence in the Institute and
their commitment to our mission to treat and, where feasible,
eliminate the diseases that afflict the world’s poorest people.
Their contributions to our endeavors will be particularly
important at this time as we embark on programmatic and
geographic expansion of our activities.”
Rt Hon Baroness Hayman has just completed a five year
term as Lord Speaker of the House of Lords, the upper chamber of
the United Kingdom parliament, where she had previously served as a
Government Minister of State, but having begun her parliamentary
career in the House of Commons in 1974. Whilst raising a
family in the intervening period, Helene Hayman was a member of the
Royal College of Obstetricians and Gynaecologists’ Ethics Committee
for fifteen years, and of the University College of London’s
Committee on Ethics of Clinical Investigation. Former public
service roles also include the inaugural Chairmanship of Cancer
Research UK, the largest charity in the UK; and of the Human Tissue
Authority, including membership of the Human Fertilisation and
Embryology Authority; and whilst Lord Speaker, President of the
Commonwealth Parliamentary Association.
Mr. Gary Rosenthal is a partner at The Sterling Group, LP
and has been associated with the firm since 1987. Mr.
Rosenthal also serves as Director and Chairman of the Compensation
Committee of Oil States International Incorporated. Mr.
Rosenthal is Chairman of the Board of Trustees at Texas Children’s
Hospital, the largest pediatric research, teaching and clinical
care institution in the United States. He is a member of the
Board of Directors of Commentary Magazine. Mr.
Rosenthal also is Chairman of the Board of the Gordon and Mary Cain
Pediatric Research Neurology Foundation, which he founded in 1989.
Previously, Mr. Rosenthal was president of Heaney Rosenthal
Incorporated. Past business directorships have included
Dresser Incorporated, Pioneer Companies and CrossCountry Energy
Corporation. Mr. Rosenthal also served as the Chairman of the
Board of Regents at the University of Houston System.
Mr. Marc Shapiro serves as Non-Executive Chairman of
Chase Bank of Texas. He is also a Director of Kimberly-Clark
Corporation, The Mexico Fund and Weingarten Realty Investors.
Mr. Shapiro is Chairman of the Board of Trustees of Baylor College
of Medicine and also serves on the boards of the Texas Medical
Center Incorporated, The Menninger Clinic and BioHouston.
Previously, Mr. Shapiro served as the Chairman of the Board
of Visitors of MD Anderson Cancer Center. Mr. Shapiro has a
long history of community involvement, having served as Chairman of
the Greater Houston Partnership, Chairman of the Houston United Way
Campaign, and founding Chairman of the Hobby Center for the
Mrs. Alisa Swidler is an active partner with the William
J. Clinton Global Foundation and Sir Richard Branson’s Foundation,
Virgin Unite. Since 2008, Mrs. Swidler has served on the Leadership
Council of Women for Women International. Mrs. Swidler was co-chair
of the One Foundation based in the United Kingdom, a Trustee at
Save the Children UK and a founding member of the Clinton Global
Initiative-Asia. Mrs. Swidler has experience both in the private
sector and in philanthropic endeavors. She is currently a
Trustee at Millennium Promise UK, Chairs The Walkabout Foundation
and served for 13 years as a Trustee at the Louise and Arde Bulova
Foundation in New York City.
About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit, 501(c)(3) organization
of scientists, researchers, and advocates dedicated to reducing
needless human suffering caused by vaccine preventable and
neglected tropical diseases. Sabin works with governments, leading
public and private organizations, and academic institutions to
provide solutions for some of the world’s most pervasive health
challenges. Since its founding in 1993 in honor of the oral polio
vaccine developer, Dr. Albert B. Sabin, the Institute has been at
the forefront of efforts to control, treat, and eliminate vaccine
preventable and neglected tropical diseases by developing new
vaccines, advocating use of existing vaccines, and promoting
increased access to affordable medical treatments. For more
information please visit href="www.sabin.org/">www.sabin.org.
Richard Hatzfeld, +1-202-842-8467, Richard.hatzfeld at sabin.org
Tags: District of Columbia, July 14, Sabin Vaccine Institute, Washington